Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
9.86
+0.12 (1.23%)
At close: Aug 29, 2025, 4:00 PM
9.85
-0.01 (-0.10%)
After-hours: Aug 29, 2025, 4:09 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $216.96 million as of August 29, 2025. Its market cap has increased by 336.31% in one year.
Market Cap
216.96M
Enterprise Value
212.22M
1-Year Change
336.31%
Ranking
Category
Stock Price
$9.86
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $216.96M, an increase of 243.80%. That is a compound annual growth rate of 23.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 216.96M | 200.02% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |